Business
Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions
Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions.
About this update from Branded Legacy Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions\r\n \r\n \r\n\r\n\r\nBranded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions\r\nPioneering Evidence-Led Innovation to Combat the Global Opioid Crisis\r\n\r\n\r\n\r\n\r\n\r\nVANCOUVER, British Columbia, Aug. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a leading diversified holdings company dedicated to pioneering health and wellness solutions, today announced a strategic partnership with Dr. Eran Bendavid, Professor at Stanford University, to strengthen addiction research through advanced evidence synthesis and policy analysis. This collaboration builds on Branded Legacy's recent acquisition of Bio-Legacy Evaluative Group and its partnership with McMaster University, reinforcing its commitment to developing evidence-led, scalable solutions for the global addiction crisis. The partnership leverages Dr. Bendavid's expertise in global health and policy with Branded Legacy's innovation in addiction-focused drug development. \"The addiction landscape is intricately shaped not just by medical science, but also by how health systems respond, especially under stress,\" said Dr. Bendavid. \"By combining rapid evidence synthesis with policy analysis, this collaboration will help ensure that innovations are both effective and implementable in real-world settings.\" Central to this alliance is Stanford's AI-powered systematic review platform, which can process and distill large volumes of scientific literature in minutes, unlike traditional reviews that take months. This enables Branded Legacy to stay aligned with the latest medical evidence in near real-time. Amin Janmohamed, CEO of Branded Legacy, stated, \"With Dr. Bendavid's systems-level insight and this state-of-the-art literature review engine, Branded Legacy gains a powerful advantage: we can integrate the latest research in near real-time, grounding our pipeline in the strongest evidence base available.\" The collaboration enhances Branded Legacy's focus on intranasal naloxone development, informed by global health modeling and real-time evidence monitoring. With the opioid crisis, driven by fentanyl, demanding fast-acting and adaptable solutio...